Iulia Diaconu

Iulia Diaconu

Company: ElevateBio

Job title: Vice President, Immunotherapy

Email: idiaconu@elevate.bio


Iulia, with over 15 years of experience in gene and cell therapy development, is responsible for leading ElevateBio’s translational immunotherapy programs and developing second generation product candidates. Prior to ElevateBio, Iulia was Associate Director of Immunotherapy at Bluebird Bio and was responsible for preclinical development of immunotherapy CAR/TCR T cell products for various oncology indications. She completed a post-doctoral fellowship at Baylor College of Medicine/ Center for Cell and Gene Therapy developing CAR T cell and virus specific T cell products for hematological cancers that translate to the clinic. Iulia has a BS in Chemistry and Clinical Medical Laboratory and an MSc in Cell/Cellular and Molecular Biology from Babes-Bolyai University, Romania, and a PhD in Pharmacy from the University of Medicine and Pharmacy “Iuliu Hatieganu,” Romania, focusing on prognostic and diagnostic markers for endometriosis and ovarian cancer. She also holds a PhD in Medicine from University of Helsinki, Finland, where she studied the efficacy and safety of oncolytic virus therapies.

Location: Cambridge, Massachusetts, United States

LinkedIn: https://www.linkedin.com/in/iulia-diaconu-7819704/

Click here to view: Introduction by Iulia Diaconu – VP Immunology – elevatebio

For contact information, please email james.milburn@hansonwade.com

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.